People suffer from many health problems these days and asthma is one such that is affecting many people all over the world. Famous pharmaceutical giant Glenmark recently launched a digital dose inhaler or DDI for asthma patients and those with other Chronic Obstructive Pulmonary Disease, COPD, and it has brought cheers now in many faces.
It must be noted that this inhaler could provide accurate digital dose counter coupled with low dose warning and it would help asthma and COPD patients to track adherence to their theraphy.
Recent statement from World Health Organization, WHO said there are 300 million people who suffer from asthma and this number could go to staggering 100 million by the year 2025.
The 250000 deaths due to asthma all over and 57500 deaths in India have created great concern for many doctors all over now.
It is said that the digihaler would be able to track the number of doses taken and indicator gives low dose warning and thereby this digihaler would be highly beneficial for the patients.
It is now expected that digital revolution would play a great role in the industry. Many patients non adherence to the treatment regime was always an issue over the years in cases of asthma but not any more by this amazing DDI. Superb news!!